Blueprint Medicines Corp (BPMC)
90.46
+0.13
(+0.14%)
USD |
NASDAQ |
Dec 24, 16:00
Blueprint Medicines Enterprise Value: 5.399B for Dec. 24, 2024
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Vertex Pharmaceuticals Inc | 98.59B |
| PTC Therapeutics Inc | 2.769B |
| Biomarin Pharmaceutical Inc | 12.36B |
| Regeneron Pharmaceuticals Inc | 70.70B |
| SpringWorks Therapeutics Inc | 2.362B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -56.28M |
| Revenue (Quarterly) | 128.18M |
| Total Expenses (Quarterly) | 177.16M |
| EPS Diluted (Quarterly) | -0.89 |
| Gross Profit Margin (Quarterly) | 98.49% |
| Profit Margin (Quarterly) | -43.90% |
| Earnings Yield | -2.33% |
| Normalized Earnings Yield | -5.336 |